View in EDS HTML Full Text PDF Full Text

Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis.

Saved in:
Bibliographic Details
Title: Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis.
Authors: Hetta, Helal F.1 (AUTHOR) hhussen@ut.edu.sa, Salama, Ayman2 (AUTHOR), Aljuaid, Turki A.3 (AUTHOR), Mojmami, Yazan T.3,4 (AUTHOR), Alotibi, Riyadh S.3,5 (AUTHOR), Alqabaly, Ahmed M.1,3 (AUTHOR), Aldosari, Nawaf A.2,3 (AUTHOR), Alshahri, Sami A.3 (AUTHOR), Asiri, Walid I. A.3,4 (AUTHOR), Alamri, Raed S.3,5 (AUTHOR), Alanazi, Fayez A.3 (AUTHOR), Alenazi, Malek S. A.3 (AUTHOR), Albuhayri, Mohammed H.3 (AUTHOR), Ramadan, Yasmin N.4 (AUTHOR), Sayad, Reem5 (AUTHOR)
Source: Pharmaceuticals (14248247). Mar2026, Vol. 19 Issue 3, p467. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 192641607
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hetta%2C+Helal+F%2E%22">Hetta, Helal F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> hhussen@ut.edu.sa</i><br /><searchLink fieldCode="AR" term="%22Salama%2C+Ayman%22">Salama, Ayman</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aljuaid%2C+Turki+A%2E%22">Aljuaid, Turki A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mojmami%2C+Yazan+T%2E%22">Mojmami, Yazan T.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alotibi%2C+Riyadh+S%2E%22">Alotibi, Riyadh S.</searchLink><relatesTo>3,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alqabaly%2C+Ahmed+M%2E%22">Alqabaly, Ahmed M.</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aldosari%2C+Nawaf+A%2E%22">Aldosari, Nawaf A.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alshahri%2C+Sami+A%2E%22">Alshahri, Sami A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Asiri%2C+Walid+I%2E+A%2E%22">Asiri, Walid I. A.</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alamri%2C+Raed+S%2E%22">Alamri, Raed S.</searchLink><relatesTo>3,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alanazi%2C+Fayez+A%2E%22">Alanazi, Fayez A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alenazi%2C+Malek+S%2E+A%2E%22">Alenazi, Malek S. A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Albuhayri%2C+Mohammed+H%2E%22">Albuhayri, Mohammed H.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ramadan%2C+Yasmin+N%2E%22">Ramadan, Yasmin N.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sayad%2C+Reem%22">Sayad, Reem</searchLink><relatesTo>5</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pharmaceuticals+%2814248247%29%22">Pharmaceuticals (14248247)</searchLink>. Mar2026, Vol. 19 Issue 3, p467. 19p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192641607
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ph19030467
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 19
        StartPage: 467
    Titles:
      – TitleFull: Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hetta, Helal F.
      – PersonEntity:
          Name:
            NameFull: Salama, Ayman
      – PersonEntity:
          Name:
            NameFull: Aljuaid, Turki A.
      – PersonEntity:
          Name:
            NameFull: Mojmami, Yazan T.
      – PersonEntity:
          Name:
            NameFull: Alotibi, Riyadh S.
      – PersonEntity:
          Name:
            NameFull: Alqabaly, Ahmed M.
      – PersonEntity:
          Name:
            NameFull: Aldosari, Nawaf A.
      – PersonEntity:
          Name:
            NameFull: Alshahri, Sami A.
      – PersonEntity:
          Name:
            NameFull: Asiri, Walid I. A.
      – PersonEntity:
          Name:
            NameFull: Alamri, Raed S.
      – PersonEntity:
          Name:
            NameFull: Alanazi, Fayez A.
      – PersonEntity:
          Name:
            NameFull: Alenazi, Malek S. A.
      – PersonEntity:
          Name:
            NameFull: Albuhayri, Mohammed H.
      – PersonEntity:
          Name:
            NameFull: Ramadan, Yasmin N.
      – PersonEntity:
          Name:
            NameFull: Sayad, Reem
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 14248247
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Pharmaceuticals (14248247)
              Type: main
ResultId 1